NeuroSolv Therapeutics LLC Advances Spinal Cord Injury Treatment with Development of Perineline™ and Support from AscellaHealth LLC, a Global Healthcare & Specialty Pharmacy Solutions Company

BERWYN, Pa. & DUBLIN--(BUSINESS WIRE)--AscellaHealth LLC, a global healthcare and specialty pharmacy solutions company, today announces its commitment to provide NeuroSolv Therapeutics LLC with AscellaHealth’s comprehensive suite of services to support NeuroSolv’s clinical development and commercialization of Perineline™, a two-part, non-surgical therapy aimed at improving the treatment options available for patients with spinal cord injury (SCI). Perineline™ allows signals to travel through the treated zone with a view to returning function to the body, through direct treatment of the Glial scar that occurs following injury to the spinal cord, combined with neural signaling interventions.

To read more, click here.